At a glance
ClinicalIndex Comparison RecordN/ACompleted· 671 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-interventional Study Describing Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 671 participants across 1 site.
Detailed Summary
Describe patient and physician assessed factors for patient well-being when treated with Pradaxa for stroke and embolism prevention in atrial fibrillation either compared to previous antithrombotic treatment (switcher)
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedJul 2016
Primary CompletionOct 2018
TodayJul 2026
First PostedJul 21, 2016
Enrollment StartJun 13, 2016
Primary CompletionOct 10, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.9 years ago